| Hans-Günter Meyer-Thompson | Fachveröffentlichungen
Dose-specific clinical outcomes in patients with opioid use disorder treated with 24-32 mg/day of buprenorphine.
Dose-specific clinical outcomes in patients with opioid use disorder treated with 24-32 mg/day of buprenorphine.
D'Agata Mount J, Sun J, Davis A, Cover A, Sun L, Gannon C, Derenoncourt M, Garrett G, Eyasu R, Ebah E, Bijole P, Greenblatt A, Kattakuzhy S, Rosenthal E.
Addiction. 2024 Nov;119(11):1964-1972. doi: 10.1111/add.16600. Epub 2024 Jul 8. PMID: 38978176.
Abstract